SGYP

Synergy Pharmaceuticals, Inc. News Headlines

$3.77
*  
0.04
1.05%
Get SGYP Alerts
*Delayed - data as of Jul. 24, 2014  -  Find a broker to begin trading SGYP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Jazz Pharmaceuticals/Concert Pharmaceuticals Start Study - Analyst Blog
7/22/2014 5:25:00 PM - Zacks.com

Anacor's Kerydin to Be Commercialized by Sandoz in the U.S. - Analyst Blog
7/22/2014 5:05:00 PM - Zacks.com

Anacor Pharmaceuticals, Inc. (ANAC) in Focus: Stock Surges 6.76% - Tale of the Tape
7/22/2014 8:44:00 AM - Zacks.com

Astellas Up on Pipeline Update, Oncology in Focus (revised) - Analyst Blog
7/21/2014 4:07:46 PM - Zacks.com

Synergy Pharmaceuticals Progresses with Mid-Stage Candidate - Analyst Blog
7/18/2014 6:15:00 PM - Zacks.com

Salix-Pharming's Ruconest Gets FDA Nod for HAE - Analyst Blog
7/18/2014 6:00:00 PM - Zacks.com

Astellas' Isavuconazole Gets QIDP for Invasive Candidiasis - Analyst Blog
7/17/2014 5:50:00 PM - Zacks.com

Genocea Biosciences, Inc. (GNCA) in Focus: Stock Rises 7.52% - Tale of the Tape
7/17/2014 8:44:00 AM - Zacks.com

Weakness Seen in Lannett Company (LCI): Stock Tumbles 17.1% - Tale of the Tape
7/17/2014 8:36:00 AM - Zacks.com

Astellas Up on Pipeline Update, Oncology in Focus - Analyst Blog
7/16/2014 3:03:00 PM - Zacks.com

Zafgen's Beloranib Gets Orphan Drug Status in the EU - Analyst Blog
7/14/2014 11:40:00 AM - Zacks.com

Sector Update: Health-Care Stocks Flat Pre-Market; Abbott Adds 1% on Sale of Generics Business to Mylan
7/14/2014 8:47:17 AM - MT Newswires

Sector Update: Health Care
7/14/2014 8:45:47 AM - MT Newswires

Strength Seen in La Jolla Pharmaceutical Co. (LJPC): Stock Shoots 19% - Tale of the Tape
7/14/2014 8:44:00 AM - Zacks.com

Synergy Pharma Reaches Halfway Mark For 1st Pivotal Phase 3 Trial Of Plecanatide
7/14/2014 6:09:00 AM - RTT News

Sarepta Plunges on Eteplirsen Study Results - Analyst Blog
7/11/2014 5:00:00 PM - Zacks.com

Regado's REGULATE-PCI Study Under Clinical Hold - Analyst Blog
7/10/2014 6:30:00 PM - Zacks.com

Astellas Seeks FDA Nod for Fungal Infection Treatment - Analyst Blog
7/10/2014 5:30:00 PM - Zacks.com

Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock up 8.37% - Tale of the Tape
7/10/2014 8:44:00 AM - Zacks.com

Weakness Seen in TherapeuticsMD (TXMD): Stock Tumbles 8.4% - Tale of the Tape
7/10/2014 8:34:00 AM - Zacks.com

Incyte Earns Milestone Payment on Japanese Approval of Jakavi - Analyst Blog
7/9/2014 6:50:00 PM - Zacks.com

Salix-Cosmo to Merge in Tax-Saving Deal - Analyst Blog
7/9/2014 5:35:00 PM - Zacks.com

Synergy Pharmaceuticals' Plecanatide to Move into Phase III - Analyst Blog
7/9/2014 5:10:00 PM - Zacks.com

Anacor's Kerydin Gets FDA Nod for Onychomycosis - Analyst Blog
7/9/2014 12:10:00 PM - Zacks.com

BioMarin's Vimizim Gets Canadian Nod - Analyst Blog
7/8/2014 6:10:00 PM - Zacks.com